Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Landa Labs (2012) Ltd. has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 4 examiners across 3 art units, showing examiner-specific prosecution with some shared technical assignment. Portfolio oversight should track both the individual records and issues that recur within an art unit.
KIM, DANIELLE A is the busiest examiner, with 1 pending matter. Because no examiner handles more than 1 pending matter in the supplied profile, counsel should not rely on a single examiner-centered strategy. Separate claim and amendment reviews remain appropriate for the pending applications.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, DANIELLE A | 1 | 36.6% | +51.9% |
| PRAGANI, RAJAN | 1 | 52.4% | +71.4% |
| WRIGHT, SARAH C | 1 | 42.1% | +45.6% |
| BABSON, NICOLE PLOURDE | 1 | 46.7% | +33.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18052223 | COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS | BABSON, NICOLE PLOURDE | 46d overdue |
| 18444693 | COMPOSITIONS AND METHODS FOR STYLING HAIR FIBERS | KIM, DANIELLE A | — |
| 18052224 | COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS | WRIGHT, SARAH C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18052223 | COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS | BABSON, NICOLE PLOURDE | 46d overdue |
| 18444693 | COMPOSITIONS AND METHODS FOR STYLING HAIR FIBERS | KIM, DANIELLE A | — |
| 18052225 | COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS | PRAGANI, RAJAN | — |
| 18052224 | COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS | WRIGHT, SARAH C | — |
| Art Unit | Apps |
|---|---|
| 1619 | 2 |
| 1613 | 1 |
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18444693 | COMPOSITIONS AND METHODS FOR STYLING HAIR FIBERS | KIM, DANIELLE A | 1613 | §103§112Other | Non-Final OA | — | Pending | Feb 18, 2024 |
| 18052225 | COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS | PRAGANI, RAJAN | 1614 | §103 | Final Rejection | — | Pending | Nov 03, 2022 |
| 18052224 | COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS | WRIGHT, SARAH C | 1619 | §103§112 | Final Rejection | — | Pending | Nov 03, 2022 |
| 18052223 | COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS | BABSON, NICOLE PLOURDE | 1619 | §103§112 | Non-Final OA | 46d overdue | Pending | Nov 03, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLanda Labs (2012) Ltd. has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Danielle A Kim has the most, with 1 of Landa Labs (2012) Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
